Sopungyangjae-Tang inhibits development of dermatitis in Nc/Nga mice

Evidence-based Complementary and Alternative Medicine

Volumn 5, Issue 2, 2008, Pages 173-180

  Pokharel, Yuba Raj ^a   Lim, Sung Chul ^a   Kim, Sang Chan ^b   Heo, Tae Hwe ^c   Choi, Hoo Kyun ^a   Kang, Keon Wook ^a  

^a Chosun University   (South Korea)

^b Daegu Haany University   (South Korea)

^c Konyang University   (South Korea)

Author keywords

Anti dermatitic activity; Atopic dermatitis; NF B; Sopungyangjae Tang; TARC

Indexed keywords

DERMATOLOGICAL AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SOPUNGYANGJAE TANG; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVATION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 44649186938     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nem015     Document Type: Article

References (23)

1. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermato-Venereol 1980;92:44-7.
2. Soter NA. Morphology of atopic eczema. Allergy 1989;44:16-9.
3. Leung DY. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997;107:25-30.
4. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997;272:15036-42.
5. Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N, Matsushima K. Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 1999;94:845-52.
6. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 Chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000;115:640-6.
7. Furukawa H, Takahashi M, Nakamura K, Kaneko F. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis. J Dermatol Sci 2004;36:165-72.
8. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-6.
9. Lee JY, Woo ER, Kang KW. Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. J Ethnopharmacol 2005;97:561-6.
10. Kotani M, Matsumoto M, Fujita A, Higa S, Wang SW, Suemura M, et al. Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allerg Clin Immunol 2000;106:159-66.
11. Gao XK, Fuseda K, Shibata T, Tanaka H, Inagaki N, Nagai H. Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice. Evid Based Complement Altern Med 2005;2:191-9.
12. Sandoval-Lopez G, Teran LM. TARC: novel mediator of allergic inflammation. Clin Exp Allergy 2001;31:1809-12.
13. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kappaB-like binding sites of the interleukin 8 gene. J Biol Chem 1992;267:22506-11.
14. de Wit H, Hoogstraten D, Halie RM, Vellenga E. Interferon-gamma modulates the lipopolysaccharide-induced expression of AP-1 and NF-kappa B at the mRNA and protein level in human monocytes. Exp Hematol 1996;24:228-35.
15. Adcock IM. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Mon Arch Chest Dis 1997;52:178-86.
16. Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 2004;78:1665-74.
17. Berin MC, Eckmann L, Broide DH, Kagnoff MF. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respi Cell Mol Biol 2001;24:382-9.
18. Komine M, Kakinuma T, Kagami S, Hanakawa Y, Hashimoto K, Tamaki K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 2005;125:491-8.
19. Wang T, Zhang X, Li JJ. The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol 2002;2:1509-20.
20. Holvoet S, Vincent C, Schmitt D, Serres M. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Exp Cell Res 2003;290:108-19.
21. Matsumoto K, Mizukoshi K, Oyobikawa M, Ohshima H, Tagami H. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments. Skin Res Technol 2004;10:122-9.
22. Middleton E Jr, Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol 1992;43:1167-79.
23. Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M, et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001;166:2055-62.